Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Neuropharmacology
|
September 9, 2023
Selective inhibition of cannabinoid CB<sub>1</sub> receptor-evoked signalling by the interacting protein GAP43
Irene B Maroto, Estefanía Moreno, Carlos Costas-Insua, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
December 15, 2023
C<sub>60</sub>-based Multivalent Glycoporphyrins Inhibit SARS-CoV-2 Specific Interaction with the DC-SIGN Transmembrane Receptor
Jennifer Patino-Alonso, Justo Cabrera-González, Javier Merino, et al.
International Archives of Otorhinolaryngology
|
January 17, 2019
An Emergent Entity: Indolent Mucormycosis of the Paranasal Sinuses. A Multicenter Study
Erika Celis-Aguilar, Alan Burgos-Páez, Nadia Villanueva-Ramos, et al.
Molecular Plant
|
July 27, 2025
Structural insights into ABA receptor agonists reveal critical features to optimize and design a broad-spectrum ABA signaling activator
Mar Bono, Cristian Mayordomo, Alberto Coego, et al.
Aging Cell
|
January 27, 2023
Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice
Andrés Pastor-Fernández, Antonio R Bertos, Arantzazu Sierra-Ramírez, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
May 15, 2015
The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world use
Julio Martinez-Cutillas, Carme Alerany-Pardo, Joaquín Borrás-Blasco, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Neuropharmacology
|
September 9, 2023
Selective inhibition of cannabinoid CB<sub>1</sub> receptor-evoked signalling by the interacting protein GAP43
Irene B Maroto, Estefanía Moreno, Carlos Costas-Insua, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
December 15, 2023
C<sub>60</sub>-based Multivalent Glycoporphyrins Inhibit SARS-CoV-2 Specific Interaction with the DC-SIGN Transmembrane Receptor
Jennifer Patino-Alonso, Justo Cabrera-González, Javier Merino, et al.
International Archives of Otorhinolaryngology
|
January 17, 2019
An Emergent Entity: Indolent Mucormycosis of the Paranasal Sinuses. A Multicenter Study
Erika Celis-Aguilar, Alan Burgos-Páez, Nadia Villanueva-Ramos, et al.
Molecular Plant
|
July 27, 2025
Structural insights into ABA receptor agonists reveal critical features to optimize and design a broad-spectrum ABA signaling activator
Mar Bono, Cristian Mayordomo, Alberto Coego, et al.
Aging Cell
|
January 27, 2023
Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice
Andrés Pastor-Fernández, Antonio R Bertos, Arantzazu Sierra-Ramírez, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
May 15, 2015
The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world use
Julio Martinez-Cutillas, Carme Alerany-Pardo, Joaquín Borrás-Blasco, et al.
Page
of 6